Skip to content

Effectiveness and Reliability of VectSelect™ Feature for Avoidance of Phrenic Nerve Stimulation in Cardiac Resynchronisation Therapy (CRT) Patients

Effectiveness and Reliability of VectSelect™ Feature for Avoidance of Phrenic Nerve Stimulation in CRT Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01244308
Acronym
Efface
Enrollment
132
Registered
2010-11-19
Start date
2008-03-31
Completion date
2011-08-31
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Phrenic nerve stimulation, LV pacing configuration, CRT, Cardiac resynchronisation therapy, Heart failure

Brief summary

It's the aim of this study to analyse efficacy and reliability of VectSelect Feature for avoidance of phrenic nerve stimulation in cardiac resynchronisation therapy (CRT) patients.

Interventions

None listed

Sponsors

Abbott Medical Devices
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* indication for CRT-D implantation / upgrade * written informed consent

Exclusion criteria

* pregnancy * age \< 18 years * patients, who cannot visit the routine follow ups (within first 3.5months) * participants to other studies with active treatment arm

Design outcomes

Primary

MeasureTime frameDescription
Amount of patients with at least one acceptable LV pacing configuration.First Follow Up after hospital discharge (approx. 1-3 months)Amount of patients with at least one acceptable, programmable LV pacing configuration. Definition of acceptable LV pacing configuration: LV pacing threshold \<=2.5V@0.5ms AND Phrenic nerve threshold is at least twice as high as LV pacing threshold AND LV pacing impedance \>=200 Ohms. Only patients with implanted CRT-D and bipolar leftventricular lead are taken into account.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026